Cytosorbents Corporation
(CTSO)
undefined
undefined%
At close: undefined
1.01
-4.73%
After-hours Dec 13, 2024, 04:29 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -28.51M | -32.81M | -24.56M | -7.84M | -19.27M | -17.21M | -8.46M | -11.94M | -8.13M | -9.32M | -4.68M | -3.66M | -5.48M | -2.91M | -2.74M | -3.02M | -3.35M | -7.67M | -80.00K |
| Depreciation & Amortization | 2.03M | 1.13M | 1.13M | 660.79K | 581.53K | 390.55K | 218.27K | 161.61K | 112.97K | 65.55K | 64.35K | 54.61K | 39.15K | 17.80K | 51.70K | 103.70K | 190.44K | 1.26M | 10.00K |
| Stock-Based Compensation | 3.70M | 3.80M | 6.20M | 4.71M | 2.84M | - | 3.31M | 2.76M | 382.28K | 695.84K | 65.47K | 63.13K | - | - | - | - | - | - | - |
| Other Working Capital | 1.10M | 3,249.00B | 145.06K | -1,424.40B | 4.03K | -738.02K | -91.98K | 145.99K | 170.14K | -384.46K | 136.20K | -422.92K | 300.81K | 214.87K | -241.85K | 70.94K | -340.97K | 484.96K | -6.00K |
| Other Non-Cash Items | -1.24M | 3.21M | 2.58M | 322.81K | 115.21K | 734.04K | 82.05K | 30.48K | -1.35M | 378.74K | 833.65K | 534.48K | 1.81M | 198.27K | 251.59K | 407.06K | 850.44K | 3.50M | 100.00K |
| Deferred Income Tax | - | - | - | -2.71M | 422.79K | 799.51K | -1.45M | 598.87K | 386.44K | 2.12M | -65.47K | -63.13K | - | - | - | - | - | - | - |
| Change in Working Capital | 2.36M | -3.56M | 641.90K | -757.87K | -1.45M | -937.77K | -160.60K | 1.66M | -413.59K | -602.26K | 290.47K | -542.03K | -197.00K | 215.53K | -241.18K | 141.78K | -317.97K | 63.28K | -80.00K |
| Operating Cash Flow | -21.66M | -28.23M | -14.01M | -5.61M | -16.76M | -10.84M | -6.46M | -6.73M | -9.01M | -6.66M | -3.49M | -3.62M | -3.83M | -2.48M | -2.67M | -2.37M | -2.63M | -2.85M | -50.00K |
| Capital Expenditures | -936.24K | -6.46M | -4.28M | -1.68M | -1.52M | -1.52M | -1.68M | -595.53K | -643.45K | -367.32K | -216.36K | -38.81K | -52.49K | -165.45K | -14.33K | -22.05K | -33.69K | -64.86K | - |
| Acquisitions | - | - | - | - | - | - | - | - | 239.84K | 214.16K | - | - | - | - | - | 22.05K | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - | - | -5.68M | -6.69M | - | - | - | - | - | -393.61K | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | 2.19M | 5.43M | 4.75M | - | - | - | 199.61K | 199.61K | 194.00K | - | - | - |
| Other Investing Acitivies | -398.12K | -368.21K | -640.01K | -967.82K | -821.95K | - | - | - | -239.84K | -214.16K | - | - | - | -199.61K | - | -22.05K | - | - | - |
| Investing Cash Flow | -936.24K | -6.46M | -4.28M | -1.68M | -1.52M | -1.52M | -1.68M | 1.60M | -890.90K | -2.31M | -216.36K | -38.81K | -52.49K | -165.45K | 185.28K | -221.66K | -33.69K | -64.86K | - |
| Debt Repayment | - | 5.00M | - | -15.00M | 5.00M | - | 5.00M | 5.00M | - | - | 1.84M | 700.00K | 1.25M | 1.34M | - | 225.00K | - | - | - |
| Common Stock Repurchased | - | -40.36K | -90.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | -335.73K | - | - | - | - | - | - | - | -704.33K | - | -760.87K | - | - |
| Other Financial Acitivies | 218.28K | -40.36K | 715.20K | 1.13M | 2.50M | 3.34M | 1.78M | 64.21K | 2.12M | 265.45K | 2.36M | 10.61K | 5.14K | - | - | 4.90M | - | - | 40.00K |
| Financial Cash Flow | 14.47M | 4.96M | 715.20K | 66.35M | 8.18M | 17.47M | 20.12M | 5.06M | 11.64M | 10.02M | 4.20M | 4.21M | 4.01M | 2.10M | 1.34M | 5.12M | -760.87K | 5.08M | 40.00K |
| Net Cash Flow | -8.22M | -29.99M | -17.60M | 59.19M | -10.14M | 5.05M | 12.08M | -71.67K | 1.71M | 1.42M | 453.69K | 542.69K | 130.98K | -539.96K | -1.15M | 2.54M | -2.66M | 2.17M | -20.00K |
| Free Cash Flow | -22.59M | -34.69M | -18.29M | -7.29M | -18.28M | -12.36M | -8.14M | -7.33M | -9.65M | -7.03M | -3.71M | -3.66M | -3.88M | -2.64M | -2.69M | -2.39M | -2.66M | -2.91M | -50.00K |